Handelsbanken Fonder Ab Novo Cure LTD Transaction History

Handelsbanken Fonder Ab

$25.3 Billion
Q3 2024

A detailed history of Handelsbanken Fonder Ab transactions in Novo Cure LTD stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 34,223 shares of NVCR stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,223

Previous 29,223 17.11%

Holding current value

$1.06 Million

Previous $501,000 6.79%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	BUY	$15.61 - $23.34 $78,050 - $116,700	5,000 Added 17.11%	34,223 $535,000
Q2 2024 Aug 05, 2024	BUY	$11.83 - $24.05 $83,993 - $170,755	7,100 Added 32.09%	29,223 $501,000
Q4 2023 Feb 01, 2024	SELL	$11.13 - $15.78 $139,380 - $197,612	-12,523 Reduced 36.15%	22,123 $330,000
Q3 2023 Oct 19, 2023	BUY	$16.15 - $42.35 $279,766 - $733,629	17,323 Added 100.0%	34,646 $560,000
Q2 2023 Aug 02, 2023	BUY	$40.29 - $82.51 $72,522 - $148,518	1,800 Added 11.6%	17,323 $719,000
Q4 2022 Feb 07, 2023	BUY	$63.98 - $85.37 $25,592 - $34,148	400 Added 2.64%	15,523 $1.14 Million
Q2 2022 Aug 03, 2022	BUY	$56.6 - $89.9 $56,600 - $89,900	1,000 Added 7.08%	15,123 $1.05 Million
Q1 2022 May 11, 2022	SELL	$60.15 - $84.52 $120,300 - $169,040	-2,000 Reduced 12.4%	14,123 $1.17 Million
Q4 2021 Feb 08, 2022	BUY	$75.08 - $121.99 $1.21 Million - $1.97 Million	16,123 New	16,123 $1.21 Million
Q3 2021 Nov 10, 2021	SELL	$116.17 - $194.55 $1.83 Million - $3.06 Million	-15,723 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$130.4 - $225.58 $2.05 Million - $3.55 Million	15,723 New	15,723 $3.49 Million
Q1 2021 Apr 29, 2021	SELL	$124.11 - $190.17 $1.98 Million - $3.03 Million	-15,923 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$112.16 - $174.14 $1.79 Million - $2.77 Million	15,923 New	15,923 $2.76 Million

Others Institutions Holding NVCR

# of Institutions

263

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.25B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab Novo Cure LTD Transaction History